Impax Laboratories and Teva Pharmaceuticals Industires  announced April 26 that the U.S. Food and Drug Administration approved the their generic versions of ezetimibe/simvastatin (Vytorin), an oral cholesterol-lowering medication.

The Partners HealthCare System and Brigham and Women’s Hospital agreed to pay $10 million to resolve allegations that the hospital’s stem cell research laboratory fraudulently obtained grant funding.

A new scientific statement published by the American Heart Association (AHA) suggests that innovative biomarker tests for heart failure could help physicians better diagnose and treat the condition.

Because the number of hospital visits and deaths related to consuming energy drinks has increased in recent years, researchers looked at how they affect the heart and blood pressure—and the findings may make physicians think differently.

An analysis conducted at the Munich Octoberfest found that acute alcohol consumption was associated with sinus tachycardia and other cardiac arrhythmias.